Navigation Links
Graymark Healthcare Sells Record Number of CPAP Devices in Q2 2010
Date:6/28/2010

re effectively supported through their adjustment to use of a CPAP device and that challenges are addressed quickly and effectively to reduce rates of therapy abandonment. Similarly, the CPAP re-supply program provides regular follow-up care and ensures that disposable elements of the CPAP are cleaned and replaced consistent with manufacturer set schedules. Patients who are not compliant with care are provided additional support to optimize their utilization of the CPAP device.

"The only way to avoid the long-term consequences of obstructive sleep apnea is for patients to consistently use their CPAP device; our comprehensive care model improves the likelihood that patients will be compliant," Nelson concluded.

Graymark Healthcare, Inc. is a diversified medical holding company that owns and operates diagnostic sleep centers that treat a wide range of sleep disorders; independent pharmacies that serve the needs of local markets; and a medical equipment company that provides both disposable and durable medical equipment. Graymark plans to continue its growth both internally and through strategic acquisitions within the medical industry.

This press release may contain forward-looking statements which are based on the Company's current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties which could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the current economic climate and other risks and uncertainties, including those enumerated and described in the Company's filings with the Securities and Exchange Commission, which filings are available on the SEC's website at

SOURCE Graymark Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. ViroPharma to Present at Three Upcoming Healthcare Conferences
4. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
5. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
6. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
7. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
11. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015  The Academy of Managed ... Drug Administration,s (FDA,s) draft guidance and proposed rule ... biosimilars, to bear a nonproprietary name with an ... seeking a decision from the FDA on the ... care stakeholders urging the agency to use the ...
(Date:8/27/2015)... -- DURECT Corporation (Nasdaq: DRRX ) announced today ... healthcare conferences.  , James E. ... Rodman & Renshaw Investment Conference on Thursday, September 10 ... held at the St. Regis Hotel in ... of the presentation will be available by accessing ...
(Date:8/27/2015)... , Aug. 27, 2015 ieCrowd™ ... in the commercial development of the company,s supplemental ... Smart Oxygen device, being developed by ieCrowd,s subsidiary ... a patient,s changing demand for oxygen based on ... 510 (k) submission for the Smart Oxygen device ...
Breaking Medicine Technology:AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2DURECT to Participate in Upcoming Healthcare Conferences 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... Watson Pharmaceuticals, Inc. (NYSE: WPI ... (FDA) approval of TRELSTAR® 22.5 mg (triptorelin pamoate for ... proven, simple and effective palliative treatment of advanced prostate ... is the first and only six-month intramuscular (IM) GnRH ...
... the bio-pharmaceutical industry, new product commercialization efforts have taken on increased importance. It,s against this backdrop that new product planning ... , ... , ... ...
Cached Medicine Technology:FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 2Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 3Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 4
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Juvent Sports ... growing list of major sports figures who are finding joint pain relief after using ... former #1 men’s tennis player in the world said, “For the first time in ...
(Date:8/31/2015)... ... August 31, 2015 , ... According to book reviewer ... Charge of Your Life with Cancer is an excellent resource for everyone since ... Cancer Solution to be helpful in explaining what cancer is in a easy to ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Intellitec Solutions announced ... by bringing on board their 8th new staff member in 2015. With the potential ... the firm. Intellitec Solutions supports Microsoft Dynamics GP, Dynamics SL, Dynamics CRM and Intacct, ...
(Date:8/31/2015)... ... August 31, 2015 , ... healthbeautydistributors.com has been in ... test marketing a doctor note service to be made available to all patients ... for each generated excuse, much less than the average daily pay of workers. ...
(Date:8/30/2015)... ... 31, 2015 , ... Avid collector Andrew Hawley from Vintage Rock Posters announces ... This hand colored artwork is one of the most coveted Doors concert posters. The ... the doors played the Shrine, the band was one of the biggest bands ...
Breaking Medicine News(10 mins):Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:New Book The Cancer Solution Is a Must Read for Everyone Affected by Cancer 2Health News:Intellitec Solutions Achieves Record Pace for New Hiring 2
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... activity, appears to be able to detect awareness in some ... new Canadian study finds. Functional MRI (fMRI) is also ... but the high cost and limited availability of these devices ...
... HealthDay Reporter , THURSDAY, Nov. 10 (HealthDay News) -- People ... restless legs syndrome, but many people with Parkinson,s do report ... new Norwegian study. People with restless legs ... legs. This typically occurs at night during rest, and the ...
... can lead to major health issues, including significant cognitive ... Departments of Neurology, Neurosurgery and Psychiatry at NYU Langone ... Nov. 10, 2011 issue of the New England ... sudden, unexpected death in epilepsy (SUDEP) and offers guidance ...
... This press release is available in German . ... mirror-inverted manner. They differ from each other like a left ... is referred to as chirality is of particular relevance to ... dioxide or methane are not chiral, many biologically relevant molecules, ...
... disease that many parents, even some doctors, mistake for ... diagnosed or treated in time, it can lead to ... genetic studies, scientists have been unable to pinpoint the ... an international team of scientists organized by Jane C. ...
... 2011)A new national initiative, IPAL-EM (Improving Palliative Care in ... palliative care when seriously ill patients are admitted to ... the role of the palliative care in emergency medicine, ... challenge of cultures and mindset. Supported by the ...
Cached Medicine News:Health News:Brain Study Suggests Some Vegetative Patients Are Aware 2Health News:Brain Study Suggests Some Vegetative Patients Are Aware 3Health News:Classic Restless Legs Syndrome Not Linked to Parkinson's 2Health News:NYU Langone expert calls for awareness, research of sudden death in patients with epilepsy 2Health News:Flexible rack systems sort molecules 2Health News:Kawasaki disease linked to wind currents 2Health News:Kawasaki disease linked to wind currents 3Health News:IPAL-EM launches to improve palliative care in emergency medicine 2
... 20 fume containment system work station ... swing-down front panel hinges from top ... opening. The sides and front ... is impervious to most chemicals. ...
... The STREP A OIA MAX test delivers ... Group A Strep with a simple, easy-to-use ... This combination of performance, speed, and ease-of-use ... while reducing overall costs for diagnosing and ...
... The FLU OIA A/B test combines performance equivalence ... of Influenza A or B with a simple, ... minutes. The test has all the same procedural ... test will enable you decrease costs for unnecessary ...
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
Medicine Products: